Logrank test
The Logrank Test, also known as the Mantel-Cox Test, is a non-parametric statistical test used to compare the survival distributions of two or more groups. It is widely used in clinical trials and epidemiology to analyze time-to-event data, particularly in studies concerning cancer and other chronic diseases where the interest is in comparing the survival experiences of different treatment or exposure groups.
Overview[edit]
The Logrank Test is based on the survival function, which estimates the probability of an event (e.g., death, relapse) not occurring by a certain time point. It is designed to test the null hypothesis that there is no difference in survival between the groups being compared, against the alternative hypothesis that there is a difference. The test is especially useful when the data are censored, meaning that for some subjects, the event of interest has not occurred by the end of the study period.
Methodology[edit]
The test statistic for the Logrank Test is calculated by comparing the observed number of events in each group at each observed event time to the number expected under the null hypothesis of equal survival curves. The expected number of events in each group is determined based on the overall event rate in the combined study population. The test statistic follows a chi-square distribution with one degree of freedom if comparing two groups.
Assumptions[edit]
The Logrank Test makes several assumptions:
- The hazard rates of the groups being compared are proportional over time, known as the Proportional hazards assumption.
- The events are independent.
- The censoring mechanism is non-informative, meaning that the reason for censoring is unrelated to the likelihood of the event.
Applications[edit]
The Logrank Test is a cornerstone in the analysis of survival data and has broad applications in medical research. It is commonly used to evaluate the efficacy of new treatments in randomized controlled trials, to assess the impact of prognostic factors in observational studies, and to compare survival rates in different patient groups.
Limitations[edit]
While the Logrank Test is a powerful tool for analyzing survival data, it has limitations. It may not be appropriate when the proportional hazards assumption is violated, or when comparing more than two groups if the survival curves cross. In such cases, alternative methods such as the Cox proportional hazards model or Kaplan-Meier estimator may be more suitable.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian